Impact of health literacy on anxiety and depressive symptoms in pregnant women in Japan during the COVID-19 pandemic.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
18 08 2022
Historique:
received: 11 01 2022
accepted: 10 08 2022
entrez: 18 8 2022
pubmed: 19 8 2022
medline: 23 8 2022
Statut: epublish

Résumé

To investigate the relationships between communicative and critical health literacy (CCHL) and anxiety and depressive symptoms (ADs) in pregnant women during the coronavirus disease 2019 (COVID-19) pandemic. A cross-sectional study was conducted and 5466 pregnant women responded in Japan in September 2020. A Kessler 6 scale (K6) score ≥ 10, an Edinburgh Postnatal Depression Scale (EPDS) score ≥ 13, and four CCHL groups were analyzed using a logistic regression model and trend test. The proportions of pregnant women with a K6 score ≥ 10 and EPDS score ≥ 13 were 13.5 and 15.4%, respectively. In comparisons with the low CCHL group, the adjusted odds ratio (95% CI) for anxiety symptoms was 0.770 (0.604-0.982) in the high CCHL group, while those for depressive symptoms were 0.777 (0.639-0.946), 0.665 (0.537-0.824), and 0.666 (0.529-0.838) in the lower, higher, and high CCHL groups (all p < 0.05), respectively, after adjustments for potential confounding factors, such as age, weeks of gestation, complications, history, number of children, marital status, education, employment, and income. Higher CCHL was associated with significantly lower adjusted odds ratios for anxiety (p for trend = 0.019) and depressive symptoms (p for trend < 0.001). These results suggest a relationship between CCHL and ADs in pregnant women during the COVID-19 pandemic.

Identifiants

pubmed: 35982222
doi: 10.1038/s41598-022-18405-3
pii: 10.1038/s41598-022-18405-3
pmc: PMC9386675
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14042

Informations de copyright

© 2022. The Author(s).

Références

Ann Med. 2021 Dec;53(1):2120-2131
pubmed: 34761972
PLoS One. 2021 Jun 4;16(6):e0252830
pubmed: 34086813
Int J Methods Psychiatr Res. 2008;17(3):152-8
pubmed: 18763695
J Health Commun. 2012;17 Suppl 3:325-38
pubmed: 23030580
J Matern Fetal Neonatal Med. 2020 Nov 26;:1-3
pubmed: 33243043
BMC Public Health. 2021 Jul 10;21(1):1365
pubmed: 34243741
Health Promot Int. 2008 Sep;23(3):269-74
pubmed: 18515303
Health Promot J Austr. 2021 Oct;32 Suppl 2:22-28
pubmed: 32780533
Health Informatics J. 2021 Jan-Mar;27(1):1460458220975466
pubmed: 33446030
Acta Obstet Gynecol Scand. 2021 Jul;100(7):1219-1229
pubmed: 33475148
Psychiatry Clin Neurosci. 2017 Dec;71(12):836-842
pubmed: 28767198
Psychiatry Res. 2021 Jul;301:113977
pubmed: 34020217
J Psychosom Obstet Gynaecol. 2021 Jun 24;:1-12
pubmed: 34165032
J Obstet Gynaecol Res. 2021 Jun;47(6):1958-1964
pubmed: 33754418
J Affect Disord. 2021 Jan 15;279:217-221
pubmed: 33069119
Midwifery. 2021 Aug;99:103013
pubmed: 33957520
Public Health. 2021 Nov;200:77-83
pubmed: 34710717
Healthcare (Basel). 2021 Jan 05;9(1):
pubmed: 33466487
Int J Soc Psychiatry. 2021 Aug;67(5):550-558
pubmed: 33040668
Health Promot Int. 2020 Dec 1;35(6):1612-1613
pubmed: 32239213
J Reprod Infertil. 2020 Jul-Sep;21(3):189-193
pubmed: 32685416
Schizophr Res. 2020 Sep;223:192-198
pubmed: 32771308
Patient Educ Couns. 2021 Feb;104(2):223-234
pubmed: 33109429
J Affect Disord. 2015 May 1;176:95-105
pubmed: 25704562
J Obstet Gynaecol Res. 2021 Sep;47(9):2990-3000
pubmed: 34137109
Lancet Public Health. 2020 May;5(5):e249-e250
pubmed: 32302535
Birth. 2021 Dec;48(4):470-479
pubmed: 34008216
PLoS One. 2020 Dec 31;15(12):e0244809
pubmed: 33382859
Arch Intern Med. 2007 Jul 23;167(14):1503-9
pubmed: 17646604
Health Promot Int. 2021 Oct 13;36(5):1473-1481
pubmed: 33351138
Diabetes Care. 2008 May;31(5):874-9
pubmed: 18299446

Auteurs

Yasuo Haruyama (Y)

Integrated Research Faculty for Advanced Medical Sciences, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Etsuko Miyagi (E)

Department of Obstetrics and Gynecology, Yokohama City University Hospital, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan. emiyagi@yokohama-cu.ac.jp.

Gen Kobashi (G)

Integrated Research Faculty for Advanced Medical Sciences, Dokkyo Medical University, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.
Department of Public Health, Dokkyo Medical University, School of Medicine, 880 Kitakobayashi, Mibu, Tochigi, 321-0293, Japan.

Soichiro Obata (S)

Perinatal Center for Maternity and Neonates, Yokohama City University Medical Center, 3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.

Takeshi Umazume (T)

Department of Obstetrics and Gynecology, Hokkaido University Graduate School of Medicine, N15W7, Kita-ku, Sapporo, Hokkaido, 060-8648, Japan.

Asuka Yoshimi (A)

Department of Psychiatry, Yokohama City University Hospital, 3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.

Akitoyo Hishimoto (A)

Department of Psychiatry, Yokohama City University Hospital, 3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.

Kentaro Kurasawa (K)

Department of Obstetrics and Gynecology, Yokohama City University Hospital, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.

Yukio Suzuki (Y)

Department of Obstetrics and Gynecology, Yokohama City University Hospital, Yokohama City University Graduate School of Medicine, 3-9, Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.

Tomoaki Ikeda (T)

Obstetrics and Gynecology, Mie University Graduate School of Medicine, 2-174, Edobashi, Tsu, Mie, 514-8507, Japan.

Tadashi Kimura (T)

Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.

Hideto Yamada (H)

Department of Obstetrics and Gynecology, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH